Skip to main content
Premium Trial:

Request an Annual Quote

TGen, 5AM Partner on Cancer Genomic Research Grant

NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute will conduct bioinformatics-based research for the National Cancer Institute's Cancer Biomedical Informatics Grid (caBIG) network through a contract with SAIC-Frederick.

The contract, which makes TGen an In Silico Research Center of Excellence (ISRCE), provides $692,00 over the first 12 months and it includes two 12-month option periods, bringing the potential value of the agreement up to nearly $2.1 million over three years.

TGen will partner with informatics company 5AM Solutions in the project, which will involve analyzing genomic data from brain tumor models and targeted therapies in order to develop personalized treatment programs.

"This will be a very unique data set, representing the largest collection of patient brain tumor models and the widest variety of therapies applied in a controlled setting,'' Michael Berens, Head of TGen's Brain Tumor Research Lab, said in a statement. "We hope to create a process where a patient's tumor would align with one of these models, and we would know which of the 20 treatments was the best one against that tumor."

The tumor models the researchers will use were developed through the Ivy Genomics Based Medicine Project, conducted at TGen using a grant from the Ben and Catherine Ivey Foundation.

The goal of the ISRCE program is to promote in silico research using caBIG tools and data in order to add scientific value to the network's cancer data sets.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.